Shuji Teramoto

Novel positive inotropic agents: synthesis and biological activities of 6-(3-amino-2-hydroxypropoxy)-2(1H)-quinolinone derivatives

Takafumi Fujioka, Shuji Teramoto, Toyoki Mori et al. · Journal of Medicinal Chemistry · 1992 · 66 citations

NMR Studies of Co·Deglycobleomycin A2 Green and Its Complex with d(CCAGGCCTGG)

Wei Wu, Dana E. Vanderwall, Shuji Teramoto et al. · Journal of the American Chemical Society · 1998 · 41 citations

Key Synthetic Analogs of Bleomycin A2 That Directly Address the Effect and Role of the Disaccharide: Demannosylbleomycin A2 and .alpha.-D-Mannopyranosyldeglycobleomycin A2

Dale L. Boger, Shuji Teramoto, Jiacheng Zhou · Journal of the American Chemical Society · 1995 · 39 citations

Pharmaceutical Science, Bioorganic Chemistry, .Alpha.-d-mannopyranosyldeglycobleomycin A2 +17

Synthesis of key analogs of bleomycin A2 that permit a systematic evaluation of the linker region: Identification of an exceptionally prominent role for the l-threonine substituent

Dale L. Boger, Steven L. Colletti, Shuji Teramoto et al. · Bioorganic & Medicinal Chemistry · 1995 · 36 citations

Natural Product Synthesis, Key Analogs, Linker Region +10

Characterization of a novel nonpeptide vasopressin V₂‐agonist, OPC‐51803, in cells transfected human vasopressin receptor subtypes

Shigeki Nakamura, Yoshitaka Yamamura, S. Itoh et al. · British Journal of Pharmacology · 2000 · 30 citations · Full text

Immunology, Human Avp V, Pharmacotherapy +19